Amgen (NasdaqGS:AMGN) 2026 Conference Transcript

Amgen (NasdaqGS:AMGN) 2026 Conference March 11, 2026 09:20 AM ET Company ParticipantsCasey Capparelli - VP of Investor RelationsJasper van Grunsven - SVP of Rare DiseasePeter Griffith - EVP and CFOOperatorWell, I think we're ready to get started. On behalf of Leerink Partners, I wanted to welcome you all to the session with Amgen. Very much my pleasure to welcome Peter Griffith, the company's CFO. Actually in between Jasper and Peter is Casey, who runs IR. Jasper van Grunsven, is that how you pronounce your ...